Browse drugs

…epth longitudinal immunological evaluation of PLWH switching to long-acting injectable cabotegravir plus rilpivirine (LA-CAB/RPV).Material and Methods Three time p…

…t (IQ) over time during follow-up from month 1 to month 31. (a) Rilpivirine IQ, (b) CAB IQ; Linear red solid line represents the IQ cut-off…

…adherence, and safety of long-acting intramuscular cabotegravir/rilpivirine (CAB/RPV) in PLHIV.Material and Methods This was a retrospectiv…

… management, reducing treatment burden and improving adherence. Cabotegravir plus rilpivirine (CAB/RPV LA) is the first complete long-acting…

…evel resistance to emtricitabine and intermediate resistance to rilpivirine. To attenuate further resistance, 4-weekly dosing of LAI-ART wa…

…V-1 reservoir dynamics of HIV during treatment with long-acting cabotegravir and rilpivirine (LA CAB/RPV) remain limited. This study aimed t…

…ctegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) vs. dolutegravir (DTG)-based single tablet regimens (STR) on treatment failure-r…

…nter study enrolled PLWH who switched to bimonthly LAI-ART with cabotegravir (CAB) and rilpivirine (RPV) between January 2023 and October 20…

…Background Long-acting (LA) cabotegravir (CAB) and rilpivirine (RPV) is an effective and well-tolerated antiretroviral switch …

…Introduction The long-acting injectable dual therapy cabotegravir + rilpivirine improves quality of life and adherence in virolog…

…Background The widespread adoption of cabotegravir (CAB)/rilpivirine (RPV) long-acting (LA) in clinical practice m…

…Background Long-acting injectable antiretroviral therapy with cabotegravir plus rilpivirine (CAB/RPV LA) represents a paradigm shift in th…